Gradient Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-64
Closed -$2.7K 626
2024
Q2
$2.7K Buy
64
+48
+300% +$2.64K ﹤0.01% 941
2024
Q1
$1.1K Buy
16
+4
+33% +$253 ﹤0.01% 894
2023
Q4
$888 Hold
12
﹤0.01% 1459
2023
Q3
$819 Sell
12
-100
-89% -$8.48K ﹤0.01% 1431
2023
Q2
$10.5K Buy
112
+12
+12% +$936 ﹤0.01% 808
2023
Q1
$6.78K Buy
+100
New +$6.43K ﹤0.01% 889
2020
Q1
Sell
-2
Closed 1130
2019
Q4
$0 Hold
2
﹤0.01% 1133
2019
Q3
$0 Buy
+2
New +$228 ﹤0.01% 1139

Other funds holding EXAS

Gradient Investments's EXAS Position: Q3 2024 in Review

Gradient Investments sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 64 shares — an estimated $2.7K sold.

Gradient Investments first reported a position in EXAS in Q3 2019 and held it in 8 quarters. The position peaked at $10.5K in Q2 2023. 598 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • Gradient Investments reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 64 Exact Sciences shares in Q3 2024, an estimated $2.7K.
  • Gradient Investments first reported a position in Exact Sciences in Q3 2019 and held it in 8 quarters.
  • Gradient Investments's Exact Sciences position peaked at $10.5K in Q2 2023.
  • 598 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.